These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12787893)

  • 21. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
    Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
    J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPLC and 1H-NMR study of chiral recognition in some thromboxane antagonists induced by beta-cyclodextrin.
    Casy AF; Cooper AD; Jefferies TM; Gaskell RM; Greatbanks D; Pickford R
    J Pharm Biomed Anal; 1991; 9(10-12):787-92. PubMed ID: 1668300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton nuclear magnetic resonance spectroscopy studies of the inclusion complex of piroxicam with beta-cyclodextrin.
    Fronza G; Mele A; Redenti E; Ventura P
    J Pharm Sci; 1992 Dec; 81(12):1162-5. PubMed ID: 1491331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the complex of beta-cyclodextrin with beta-naphthyloxyacetic acid in the solid state and in aqueous solution.
    Kokkinou A; Yannakopoulou K; Mavridis IM; Mentzafo D
    Carbohydr Res; 2001 May; 332(1):85-94. PubMed ID: 11403091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative proton nuclear magnetic resonance studies of amantadine complexes formed in aqueous solutions with three major cyclodextrins.
    Lis-Cieplak A; Sitkowski J; Kolodziejski W
    J Pharm Sci; 2014 Jan; 103(1):274-82. PubMed ID: 24282085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The crystal structure of the 1:1 inclusion complex of beta-cyclodextrin with squaric acid.
    Crisma M; Fornasier R; Marcuzzi F
    Carbohydr Res; 2001 Jul; 333(2):145-51. PubMed ID: 11448675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of second-order association constants by global analysis of 1H and 13C NMR chemical shifts. Application to the complexation of sodium fusidate and potassium helvolate by beta- and gamma-cyclodextrin.
    Al-Soufi W; Cabrer PR; Jover A; Budal RM; Tato JV
    Steroids; 2003 Jan; 68(1):43-53. PubMed ID: 12475722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.
    Figueiras A; Sarraguça JM; Carvalho RA; Pais AA; Veiga FJ
    Pharm Res; 2007 Feb; 24(2):377-89. PubMed ID: 17177111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR spectra and structures of oridonin derivatives complexes with β-cyclodextrin.
    Liu W; Zhao B; Li YC; Liu HM
    Magn Reson Chem; 2011 Sep; 49(9):611-5. PubMed ID: 21815208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of imazalil/beta-cyclodextrin inclusion complex.
    Consonni R; Recca T; Dettori MA; Fabbri D; Delogu G
    J Agric Food Chem; 2004 Mar; 52(6):1590-3. PubMed ID: 15030216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.
    Ribeiro L; Carvalho RA; Ferreira DC; Veiga FJ
    Eur J Pharm Sci; 2005 Jan; 24(1):1-13. PubMed ID: 15626573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
    Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
    Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR spectroscopic characterization of metoprolol/cyclodextrin complexes in aqueous solution: cavity size dependency.
    Ikeda Y; Hirayama F; Arima H; Uekama K; Yoshitake Y; Harano K
    J Pharm Sci; 2004 Jul; 93(7):1659-71. PubMed ID: 15176056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion complexation of the sunscreen agent 2-ethylhexyl-p-dimethylaminobenzoate with hydroxypropyl-beta-cyclodextrin: effect on photostability.
    Scalia S; Villani S; Casolari A
    J Pharm Pharmacol; 1999 Dec; 51(12):1367-74. PubMed ID: 10678490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution.
    Boonyarattanakalin K; Wolschann P; Toochinda P; Lawtrakul L
    Eur J Pharm Sci; 2012 Nov; 47(4):752-8. PubMed ID: 22922099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling of beta-cyclodextrin complexes with nootropic drugs.
    Amato ME; Djedaïni F; Pappalardo GC; Perly B; Scarlata G
    J Pharm Sci; 1992 Dec; 81(12):1157-61. PubMed ID: 1491330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of steroid/cyclodextrin inclusion compounds by x-ray powder diffractometry and thermal analysis.
    Lin SZ; Kohyama N; Tsuruta H
    Ind Health; 1996; 34(2):143-8. PubMed ID: 8857285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
    Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
    Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling and conformation analysis of beta-cyclodextrin complexes.
    Kostense AS; van Helden SP; Janssen LH
    J Comput Aided Mol Des; 1991 Dec; 5(6):525-43. PubMed ID: 1818089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta-cyclodextrin inclusion complexes: effect of the host substitution on molecular recognition].
    Barczáné BA; Barcza L
    Acta Pharm Hung; 2000; 70(3-6):82-8. PubMed ID: 11379035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.